If Pfizer bought sanofi then the French would have no large pharma player. The French overpaid for Aventis to prevent Novartis from buying it for the very same reason. French government intervened to allow French banks to finance Aventis deal.
The sanofi Aventis deal was the demise of the company . It's been downhill ever since. Sanofi paid way to much for Aventis and Gensyme( Viehbacher deal). You can thank the past geniuses Deheeq and Viehbacher for our current turd status circling the toilet now.
I can't think of a more mismanaged company . Analyst all agree to stay clear of this stock . Wall Street leaned their lesson with the Accomplia debacle. Sanofi never has been the same since . A shame to see so many good people at Sanofi in 90's and up to mid 2000's. The clown show since 2009 is worthy of a Saturday Night Live skit.
There is no way Pfizer executives could be that stupid. It would take billions beyond the original purchase price to undo the morass created by Sanofi executives over the last decade.
Never say never. Increasingly it has been a trend in big pharma to swap assets in order for both companies to get a bigger presence in the remaining business. It is unlikely that Pfizer would purchase Sanofi, that would create a host of political issues, but they might grab a division or two. Sanofi sold off the animal health sector to Boehringer Ingelheim this year, and Pfizer is out shopping their consumer brands (Glaxo is a rumor) which could bring them $10 billion or so in proceeds. If I were a betting man, I would expect Pfizer to be more interested in the vaccines than the Genzyme products, simply because there is not much more you can do on profit margins on the Genzyme portfolio, but Pfizer knows to how to merge sales forces and save some bucks so vaccines would give them that opportunity. Sanofi is on their way to the butcher's shop. Not a single one of the segments has a leadership position now that Lantus is no longer the playground bully, which means the best value is to be had by selling off the pieces while there is still strong sales. Oncology and immunology aren't going to last long.
Never going to happen. Pharma companies sell off units that can't compete or are unprofitable (Novartis vaccines to GSK, Sanofi animal health to BI, etc). They don't sell off pieces that contribute significant profit ( Pastuer, Genzyme) and are currently bailing out other parts of the ship that are leaking (diabetes, cv, etc). We have nothing for sale they would want.
Zactly my thoughts. What products would any company want from Sanofi? Name one? Nobody wants anything from the stinky french company. Nope, nada, not today, not ever.
This would compare to going to a Salvation Army to do all your clothes and furniture shopping. There is nothing but used hand me downs at Sanofi. We can thank the leadership at Sanofi post 2005 for this current mess.
It actually wouldn't surprise me if they bought Genzyme. Genzyme rare is the only thing making Sanofi any money. And it keeps growing. Sanofi needs Genzyme, but money always talks.
There are plenty of decent products in Sanofi's portfolio. Note that I said decent products, not blockbuster market leading products. There is a big difference. The innovative pharma companies compete on product features, research pipelines, and lastly on price. The generic companies compete on manufacturing efficiency, ruthless cost cutting, but mainly on price. Sanofi is stuck in the middle with a shitty pipeline and unable to compete on cost so the company is at a fork in the road. Either way, there need to be some changes and some of those unexciting products may have more value in the hands of a different company who is better positioned to market them effectively. That is how deals are done. The big question is whether Sanofi has so few cash producing segments left that it can afford to sell them off to get the cash needed to restructure gracefully. While I think that Sanofi has about as much chance of becoming a research powerhouse as Nancy Pelosi has a chance of becoming a stand-up comedienne, never underestimate the power of free money. The EU framework program throws billions of Euros at research projects that have limited merit, but which keep Europeans employed. Who knows if Sanofi does something remarkable in spite of themselves; even a blind squirrel finds an acorn once in a while.
sanofi spent $12 billion on Accomplia which kept a whole bunch of folks employed for at least five years and then the drug failed. They musta known the rats were committing suicide way early but DeHeq let it go on till the FDA made the train stop. Stock holders let him steal that money to support his Caesar like power trip.
Yes Wall St andthe FDA never forgave Sanofi for Accomplia. Despite what they were seeing in clinical trials of people jumping out windows, off cliffs, skyscrapers etc Deheeq pushed forward. If only he had brushed up on French war heros and the art of surrendering the company would of saved billions. Viva LA
